Seminars in Oncology
Volume 29, Issue 2 , Pages 152-159 , April 2002

Radioembolization for hepatic metastases

References 

  1. Burton MA, Gray BN, Kelleher DK, et al.  Selective internal radiation therapy: Validation of intraoperative dosimetry. Radiology. 1990;175:253–255
  2. Mantravadi RVP, Spigos DG, Tan WS, et al.  Intraarterial yttrium 90 in the treatment of hepatic malignancy. Radiology. 1982;142:783–786
  3. Herba MJ, Illescas FF, Thirlwell MP, et al.  Hepatic malignancies: improved treatment with intraarterial Y 90. Radiology. 1988;169:311–314
  4. Nakamura H, Tanaka M, Oi H. Hepatic embolization from the common hepatic artery using balloon occlusion technique. Am J Radiol. 1985;145:115–116
  5. Michels NA. Blood Supply and Anatomy of the Upper Abdominal Organs: With a Descriptive Atlas. Philadelphia: PA, Lippincott; 1955;
  6. Gyves JW, Ziessman HA, Ensminger WD, et al.  Definition of hepatic tumor microcirculation by single photon emission computerized tomography (SPECT). J Nucl Med. 1984;25:972–977
  7. Andrews JC, Walker SC, Ackermann RJ, et al.  Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up. J Nucl Med. 1994;35:1637–1644
  8. Ho S, Lau WY, Leung TWT, et al.  Tumour-to-normal uptake ratio of Y 90 microspheres in hepatic cancer assesed with 99Tcm macroaggregated albumin. Br J Radiol. 1997;70:823–828
  9. Ho S, Lau WY, Leung TWT, et al.  Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 mircrospheres in the treatment of hepatic cancer. Eur J Nucl Med. 1997;24:293–298
  10. Andrews JC, Waker-Andrews SC, Juni JE, et al.  Modulation of liver tumor blood flow with hepatic arterial epinephrin: A SPECT study. Radiology. 1989;173:645–647
  11. Yorke ED, Jackson A, Fox RA, et al.  Can current models explain the lack of liver complications in Y 90 microsphere therapy?. Clin Cancer Res. 1999;5:3024–3030 (suppl)
  12. Campbell AM, Bailey IH, Burton MA. Analysis of distribution of intra-arterial microspheres in human liver following hepatic yttrium-90 microsphere therapy. Phys Med Biol. 2000;45:1023–1033
  13. Marn CS, Andrews JC, Francis IR, et al.  Hepatic parenchymal changes after intraarterial Y 90 therapy: CT findings. Radiology. 1993;187:125–128
  14. Alterman DD, Barbour J, Glazer GM, et al.  CT evaluation of extrahepatic disease in patients with metastatic colorectal carcinoma receiving hepatic arterial chemotherapy. J Can Assoc Radiol. 1987;38:215–218

 Supported in part by Theragenics Corp, Atlanta, GA.

☆☆ Address reprint requests to Milton J. Herba, MD, Montreal General Hospital, Department of Radiology, 1650 Cedar Ave, Montreal, QC H3G 1A4, Canada.

PII: S0093-7754(02)50136-6

doi: 10.1053/sonc.2002.31672

Seminars in Oncology
Volume 29, Issue 2 , Pages 152-159 , April 2002